Tumor necrosis factor-α confers resistance to hypoxic injury in the adult mammalian cardiac myocyte

被引:119
作者
Nakano, M [1 ]
Knowlton, AA [1 ]
Dibbs, Z [1 ]
Mann, DL [1 ]
机构
[1] Baylor Coll Med, Cardiol Sect, Vet Adm Med Ctr, Dept Med, Houston, TX 77030 USA
关键词
myocytes; hypoxia; proteins; genes;
D O I
10.1161/01.CIR.97.14.1392
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Previous studies in isolated cardiac myocytes have shown that tumor necrosis factor (TNF)-alpha: provokes increased expression of 27- and 70-kD stress proteins as well as manganese superoxide dismutase, suggesting that TNF-alpha might play a role in mediating stress responses in the heart. Methods and Results-To determine whether TNF-alpha stimulation would protect isolated cardiac myocytes against environmental stress, myocyte cultures were pretreated with TNF-alpha for 12 hours and then subjected to continuous hypoxic injury (O-2 content, 3 to 5 ppm) for 12 hours, followed by reoxygenation. Cell injury was assessed in terms of lactic dehydrogenase (LDH) release, Ca-45(2+) uptake, and MTT metabolism. Pretreatment with TNF-alpha concentrations greater than or equal to 50 U/mL significantly attenuated LDH release by hypoxic cells compared with diluent-treated hypoxic cells. Similar findings were observed with respect to Ca-45(2+) uptake and MTT metabolism in TNF-alpha-pretreated cells that were subjected to prolonged hypoxia. To determine the mechanism for the TNF-alpha-induced protective effect, the cells were pretreated with heat shock protein (HSP) 72 antisense oligonucleotides. These studies showed that the protective effect of TNF-alpha was not inhibited by antisense oligonucleotides, despite use of a concentration of antisense that was sufficient to attenuate the TNF-alpha-induced increase in HSP 72 expression. Subsequent studies using mutated TNF ligands showed that activation of both types 1 and 2 TNF receptors was sufficient to confer a protective response in isolated cardiac myocytes through an as yet unknown pathway(s). Conclusions-Taken together, the above observations demonstrate that TNF-alpha pretreatment confers resistance to hypoxic stress in the adult cardiac myocyte through a novel mechanism that appears to be different from but not necessarily exclusive of the protective response conferred by HSP 72 expression.
引用
收藏
页码:1392 / 1400
页数:9
相关论文
共 62 条
[1]  
[Anonymous], 1983, J IMMUNOL METH
[2]   NUCLEAR ACCUMULATION OF INTERFERON-GAMMA [J].
BADER, T ;
WIETZERBIN, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11831-11835
[3]   SERUM TUMOR-NECROSIS-FACTOR LEVELS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA-PECTORIS [J].
BASARAN, Y ;
BASARAN, MM ;
BABACAN, KF ;
ENER, B ;
OKAY, T ;
GOK, H ;
OZDEMIR, M .
ANGIOLOGY, 1993, 44 (04) :332-337
[4]  
BOGOYEVITCH MA, 1994, J BIOL CHEM, V269, P1110
[5]   ISOLATION, CHARACTERIZATION, AND LOCALIZATION OF HEPARIN-BINDING GROWTH-FACTORS IN THE HEART [J].
CASSCELLS, W ;
SPEIR, E ;
SASSE, J ;
KLAGSBRUN, M ;
ALLEN, P ;
LEE, M ;
CALVO, B ;
CHIBA, M ;
HAGGROTH, L ;
FOLKMAN, J ;
EPSTEIN, SE .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (02) :433-441
[6]   TUMOR-NECROSIS-FACTOR-ALPHA PRETREATMENT IS PROTECTIVE IN A RAT MODEL OF MYOCARDIAL ISCHEMIA-REPERFUSION INJURY [J].
EDDY, LJ ;
GOEDDEL, DV ;
WONG, GHW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 184 (02) :1056-1059
[7]  
EGHBALI M, 1989, CELL TISSUE RES, V256, P553
[8]   TUMOR-NECROSIS-FACTOR CHALLENGES IN CANINES - PATTERNS OF CARDIOVASCULAR DYSFUNCTION [J].
EICHENHOLZ, PW ;
EICHACKER, PQ ;
HOFFMAN, WD ;
BANKS, SM ;
PARRILLO, JE ;
DANNER, RL ;
NATANSON, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (03) :H668-H675
[9]   INHIBITION OF TUMOR-NECROSIS-FACTOR PREVENTS MYOCARDIAL DYSFUNCTION DURING BURN SHOCK [J].
GIROIR, BP ;
HORTON, JW ;
WHITE, DJ ;
MCINTYRE, KL ;
LIN, CQ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (01) :H118-H124
[10]   THE TISSUE DISTRIBUTION OF TUMOR-NECROSIS-FACTOR BIOSYNTHESIS DURING ENDOTOXEMIA [J].
GIROIR, BP ;
JOHNSON, JH ;
BROWN, T ;
ALLEN, GL ;
BEUTLER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :693-698